medigraphic.com
SPANISH

Archivos de Neurociencias

Instituto Nacional de Neurología y Neurocirugía
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2007, Number 3

<< Back Next >>

Arch Neurocien 2007; 12 (3)

Neurology evolution in National Institute of Neurology and Neurosurgery Manuel Velasco Suárez

Rubio DF
Full text How to cite this article

Language: Spanish
References: 18
Page: 176-179
PDF size: 57.52 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Ricardo Rojas-García. Anticuerpos anti-GQ1b: utilidad de su determinación en el diagnóstico del síndrome de Miller Fisher. Med Clin (Barc) 2001; 116: 761-4.

  2. James R, Overell, Hung Willison. Recent developments in Miller Fisher syndrome and related disorders. Curr Opin Neurol 2005; 18:562-6.

  3. Kerry H, Levin. Variants and mimics of Guillain Barré syndrome. Neurologist 2004:10:61-74.

  4. Michiaki Koga, Nobuhiro Yuki, Tadashi Tai, Koichi Hirata. Miller Fisher syndrome and Haemophilus influenzae infection. Neurology 2001; 57:686-91.

  5. LF. Silva, CB. Panfilo, Hernández Fustes, O. Hernández-Cosio, OJ Hernández-Fustes. Síndrome de Miller Fisher y angioma cavernoso. Rev Neurol 1999; (11):1507-9.

  6. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001; 56:1104-6.

  7. M. Koga. Antecedent infections in Fisher syndrome. Neurology 2005;64:1605-11.

  8. Masaki Takahashi, Michiaki Koga, Keiko Yokoyama, Nobuhiro Yuki. Epidemiology of campylobacter jejuni isolated from patients with Guillain-Barre and Fisher syndromes in Japan. J Clin Microbiol 2005;43(1):335-9.

  9. Tan H, Caner I, Deniz O, Büyükavci. Miller Fisher syndrome with negative anti-GQ1b Immunoglobulin G antibodies. Pediatric Neurology 2003; 29:349-50.

  10. Ang CW, Noordzij PG, Klerk MA, Endtz HP, Van Doorn PA, Laman JD. Ganglioside Mimicry of campylobacter jejuni Lipopolysaccharides determines antiganglioside specificity in rabbits. Rev Infection Immunity. 2002;70:5081-5.

  11. E. Gallardo, R. Rojas, I. Anticuerpos relevantes en neuropatías disinmunes. Rev Neurol 2000; 30(6):510-4.

  12. Buompadre MC, Gáñez LA, Miranda M, Arroyo HA. Variantes inusuales del síndrome de Guillain-Barre en la infancia. Rev Neurol 2006; 42 (2): 85-90.

  13. Ortega Martínez MG, Jaramillo Rangel G, Ancer Rodríguez J, Trujillo JR. Mimetismo molecular en la neuropatogenesis del Síndrome de Guillain-Barre. Rev Mex Neurociencias 2005; 6(5):440-7.

  14. Ito M, Odaka M, Koga M. Clinical features and treatment of Fisher syndrome. Rinsho Shinkeigaku 2005;45(7):514-7.

  15. Serradell Pou A. Neuropatías disinmunes adquiridas. Sintomatología clínica y clasificación. Neurol 2000; 30 (6): 501-10.

  16. Beatrix Schwerer, Andrea Neisser, Hanno Bernheimer. Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQIb in Miller Fisher syndrome following different types of infection. Rev Infection Immunity 1999; 67(5) 2414-20.

  17. Kasper, Hauser, Braunwald, Fauci, Longo, Jameson. Principles of internal Medicine 16" edition. 2005.

  18. Pascual-Pascual SI. Aspectos actuales de las neuropatías inflamatorias agudas y crónicas. Síndrome de Guillain-Barrè y polineuritis crónica inflamatoria desmielinizante. Rev Neurol 2002; 35: 269-7.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Neurocien. 2007;12